nach oben

Journal of Bone and Mineral Metabolism

Erschienen in:

26.03.2016 | Original Article

Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children

verfasst von: Svenja Kristin Kunert, Hans Hartmann, Dieter Haffner, Maren Leifheit-Nestler

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The fibroblast growth factor (FGF) 23/Klotho axis is a principal regulator of phosphate hemostasis and vitamin D metabolism, but limited data is available on its role in the central nervous system. Here, we investigate soluble α-Klotho (sKlotho) and C-terminal as well as intact FGF23 in cerebrospinal fluid (CSF) and plasma and their relationship to mineral metabolism parameters in humans. In 39 children aged 0.3–16.8 years undergoing lumbar puncture for the exclusion of inflammatory neurological disease, sKlotho and FGF23 were investigated by Western blot analysis, followed by ELISA quantification in CSF and plasma. The percentage of intrathecal synthesis of both proteins was calculated by measuring both the expected and observed CSF/plasma ratios of sKlotho and FGF23. The secreted (KL1) and cleaved (KL1+KL2) isoforms of sKlotho, and FGF23 were clearly detected in CSF in all subjects, although protein levels were lower compared to those of plasma samples (each p < 0.01). The intrathecal percentage of CSF sKlotho and FGF23 synthesis amounted to 98 and 99 %, respectively. CSF sKlotho levels were higher in boys than in girls (p < 0.01), and correlated positively with plasma C-terminal FGF23 concentrations (p < 0.05) and standardized height (p < 0.01). Importantly, there were no significant correlations between plasma and CSF levels of sKlotho or FGF23. Plasma sKlotho as well as C-terminal and intact FGF23, respectively, were associated with parameters of mineral metabolism These results provide evidence that cleaved and secreted sKlotho and FGF23 are present in CSF, mainly derived from brain and affected by sex, height, and mineral metabolism parameters in children. Nevertheless, the absence of significant associations between plasma and CSF levels of Klotho and FGF23, respectively, suggest that the regulation of Klotho and FGF23 may be different between organs secreting these hormones into blood and CSF.

Nur mit Berechtigung zugänglich

Liu S, Quarles LD (2007) How fibroblast growth factor 23 works. J Am Soc Nephrol 18:1637–1647CrossRefPubMed

Razzaque MS (2009) The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5:611–619CrossRefPubMedPubMedCentral

Forster RE, Jurutka PW, Hsieh JC, Haussler CA, Lowmiller CL, Kaneko I, Haussler MR, Kerr Whitfield G (2011) Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 414:557–562CrossRefPubMedPubMedCentral

Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism—pivotal role of fibroblast growth factor 23. Intern Med 47:337–343CrossRefPubMed

Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419–37426CrossRefPubMed

Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD (2006) Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38–E49CrossRefPubMed

Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116:3150–3159CrossRefPubMedPubMedCentral

Yamashita T, Yoshioka M, Itoh N (2000) Identification of a novel fibroblastgrowth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277:494–498CrossRefPubMed

Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA (2010) Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24:2050–2064CrossRefPubMedPubMedCentral

10.

Jongbloed F, Galassi A, Cozzolino M, Zietse R, Chiarelli G, Cusi D, Brancaccio D, Gallieni M (2011) Clinical significance of FGF-23 measurement in dialysis patients. Clin Nephrol 76:201–209CrossRefPubMed

11.

Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y (2007) Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 18:2683–2688CrossRefPubMed

12.

Itoh N, Ornitz DM (2008) Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237:18–27CrossRefPubMed

13.

Kuro-o M (2010) Overview of the FGF23-Klotho axis. Pediatr Nephrol 25:583–590CrossRefPubMed

14.

Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6:743–750CrossRefPubMed

15.

Mian IS (1998) Sequence, structural, functional, and phylogenetic analyses of three glycosidase families. Blood Cells Mol Dis 24:83–100PubMed

16.

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45–51CrossRefPubMed

17.

Torres PU, Prie D, Molina-Bletry V, Beck L, Silve C, Friedlander G (2007) Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 71:730–737CrossRefPubMed

18.

Clinton S, Glover M, Maltare A, Laszczyk A, Mehi S, Simmons R, King G (2013) Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood. Brain Res 1527:1–14CrossRefPubMedPubMedCentral

19.

German D, Khobahy I, Pastor J, Kuro-O M, Liu X (2012) Nuclear localization of in brain: an anti-aging protein. Neurobiol Aging 33:1483.e25–30

20.

Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120–6123CrossRefPubMedPubMedCentral

21.

Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770–774CrossRefPubMed

22.

Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 104:19796–19801CrossRefPubMedPubMedCentral

23.

Bloch L, Sineshchekova O, Reichenbach D, Reiss K, Saftig P, Kuro-o M, Kaether C (2009) Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett 583:3221–3224CrossRefPubMedPubMedCentral

24.

Kuro-o M (2010) Klotho. Pflugers Arch 459:333–343CrossRefPubMed

25.

Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N, Fujimori T, Nabeshima Y (2004) Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett 565:143–147CrossRefPubMed

26.

Hu MC, Shi M, Zhang J, Quinones H, Kuro-o M, Moe OW (2010) Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 78:1240–1251CrossRefPubMedPubMedCentral

27.

Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, Nabeshima Y (1998) Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242:626–630CrossRefPubMed

28.

Tohyama O, Imura A, Iwano A, Iwano A, Freund J-N, Henrissat B, Fujimori T, Nabeshima Y (2004) Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. J Biol Chem 279:9777–9784CrossRefPubMed

29.

Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833CrossRefPubMedPubMedCentral

30.

Drew DA, Tighiouart H, Scott TM, Lou KV, Fan L, Shaffi K, Weiner DE, Sarnak MJ (2014) FGF-23 and cognitive performance in hemodialysis patients. Hemodial Int 18:78–86CrossRefPubMed

31.

Hartmann H, Hawellek N, Wedekin M, Vogel C, Das AM, Balonwu K, Ehrich J, Haffner D, Pape L (2015) Early kidney transplantation improves neurocognitive outcome in patients with severe congenital chronic kidney disease. Transpl Int 28:429–436CrossRefPubMed

32.

Sarnak M, Tighiouart H, Scott T, Lou KV, Sorensen EP, Giang LM, Drew DA, Shaffi K, Strom JA, Singh AK, Weiner DE (2013) Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology 80:471–480CrossRefPubMedPubMedCentral

33.

Liu P, Chen L, Bai X, Karaplis A, Miao D, Gu N (2011) Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23. Brain Res 1412:9–17CrossRefPubMed

34.

Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985CrossRefPubMed

35.

Barth JH, Jones RG, Payne RB (2000) Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram. Ann Clin Biochem 37:79–81CrossRefPubMed

36.

Jaeger U, Zellner K, Kromeyer-Hauschild K, Ludde R, Eisele R, Hebebrand J (2001) Body height, body weight and body mass index of German military recruits. Historical retrospect and current status. Anthropol Anz 59:251–273PubMed

37.

Neuhauser H, Schienkiewitz A, Schaffrath Rosario A, Dortschy R, Kurth BM, Ellert U, Stolzenberg H (2013) Referenzperzentile für anthropometrische Maßzahlen und Blutdruck aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS) 2003–2006. Robert-Koch-Institut, Berlin

38.

Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685CrossRefPubMed

39.

Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Grønning M (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897–902CrossRefPubMedPubMedCentral

40.

Reiber H, Thompson EJ, Grimsley G, Bernardi G, Adam P, Monteiro de Almeida S, Fredman P, Keir G, Lammers M, Liblau R, Menna-Barreto M, Sá MJ, Seres E, Sindic CJ, Teelken A, Trendelenburg C, Trojano M, van Antwerpen MP, Verbeek MM (2003) Quality assurance for cerebrospinal fluid protein analysis: international consensus by an Internet-based group discussion. Clin Chem Lab Med 41:331–337CrossRefPubMed

41.

Reiber H, Otto M, Trendelenburg C, Wormek A (2001) Reporting cerebrospinal fluid data: knowledge base and interpretation software. Clin Chem Lab Med 39:324–332CrossRefPubMed

42.

Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184:101–122CrossRefPubMed

43.

Reiber H (2006) Liquordiagnostik. In: Berlit P (ed) Klinische Neurologie, 2nd edn. Springer, Berlin, pp 136–170CrossRef

44.

Reiber H, Albaum W (2012) CSF research program

45.

Felgenhauer K (1974) Protein size and cerebrospinal fluid composition. Klin Wochenschr 52:1158–1164CrossRefPubMed

46.

Felgenhauer K, Liappis N, Nekic M (1982) Low molecular solutes and the blood cerebrospinal fluid barrier. Klin Wochenschr 60:1385–1392CrossRefPubMed

47.

Felgenhauer K, Beuche W (1999) Labordiagnostik neurologischer Erkrankungen: Liquoranalytik und -zytologie, Diagnose- und Prozessmarker. Thieme, Stuttgart

48.

Rippe B, Stelin G (1989) Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism. Kidney Int 35:1234–1244CrossRefPubMed

49.

Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK et al (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27:3417–3428CrossRefPubMedPubMedCentral

50.

Yamashita T (2005) Structural and biochemical properties of fibroblast growth factor 23. Ther Apher Dial 9:313–318CrossRefPubMed

51.

Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D (2012) Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem 49:546–553CrossRefPubMed

52.

Duce JA, Podvin S, Hollander W, Kipling D, Rosene DL, Abraham CR (2008) Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey. Glia 56:106–117CrossRefPubMed

53.

Li SA, Watanabe M, Yamada H, Nagai A, Kinuta M, Takei K (2004) Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct 29:91–99CrossRefPubMed

54.

Oz O, Hajibeigi A, Zerwekh J, Bindels R, Kuroo M, Pak C (2006) Estrogen Regulates Expression of the Molecular Machinery Controlling Calcium Reabsorption in the Distal Convoluted Tubule. ASBMR 28th Annual Meeting

55.

Semba RD, Moghekar AR, Hu J, Sun K, Turner R, Ferrucci L, O’Brien R (2013) Klotho in the cerebrospinal fluid of adults with and without Alzheimer’s disease. Neurosci Lett 558:37–40CrossRefPubMedPubMedCentral

56.

Siahanidou T, Garatzioti M, Lazaropoulou C, Kourlaba G, Papassotiriou I, Kino T, Imura A, Nabeshima Y, Chrousos G (2012) Plasma soluble alpha-klotho protein levels in premature and term neonates: correlations with growth and metabolic parameters. Eur J Endocrinol 167:433–440CrossRefPubMedPubMedCentral

57.

Shahmoon S, Rubinfeld H, Wolf I, Cohen ZR, Hadani M, Shimon I, Rubinek T (2014) The aging supressor klotho: a potential regulator of growth hormone secretion. Am J Physiol Endocrinol Metab 307:E326–E334CrossRefPubMed

58.

Kashimada K, Ymashita T, Tsuji K, Nifuji A, Mizutani S, Sabeshima Y, Noda M (2002) Defects in growth and bone metabolism in klotho mutant mice are resistant to GH treatment. J Endocrinol 174:403–410CrossRefPubMed

59.

Uchida A, Komiya Y, Tashiro T, Yorifuji H, Kishimoto T, Nabeshima Y, Hisanaga S (2001) Neurofilaments of Klotho, the mutant mouse prematurely displaying symptoms resembling human aging. J Neurosci Res 64:364–370CrossRefPubMed

60.

Chen CD, Sloane JA, Li H, Aytan N, Giannaris EL, Zeldich E, Hinman JD, Dedeoglu A, Dl Rosene, Bansal R, Luebke JI, Kuro-o M, Abraham CR (2013) The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS. J Neurosci 33:1927–1939CrossRefPubMedPubMedCentral

61.

Zeldich E, Chen CD, Avila R, Medicetty S, Abraham CR (2015) The anti-aging protein klotho enhances remyelination following cuprizone-induced demyelination. J Mol Neurosci 57:185–196CrossRefPubMed

62.

Voortman T, van den Hooven EH, Heijboer AC, Hofman A, Jaddoe VW, Franco OH (2015) Vitamin D deficiency in school-age children is associated with sociodemographic and lifestyle factors. J Nutr 145:791–798CrossRefPubMed

63.

Gkentzi D, Efthymiadou A, Kritikou D, Chrysis D (2014) Fibroblast growth factor 23 and Klotho serum levels in healthy children. Bone 66C:8–14CrossRef

64.

Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J et al (2010) Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 398:513–518CrossRefPubMedPubMedCentral

Titel: Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children
verfasst von: Svenja Kristin Kunert
Hans Hartmann
Dieter Haffner
Maren Leifheit-Nestler
Publikationsdatum: 26.03.2016
Verlag: Springer Japan
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 2/2017
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-016-0746-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Vitamin D-binding protein, vitamin D status and serum bioavailable 25(OH)D of young Asian Indian males working in outdoor and indoor environments

Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection

Predicting bone mineral acquisition during puberty: data from a 3-year follow-up study in Hamamatsu, Japan

Letter to the Editor on “Vitamin D-binding protein, vitamin D status and serum bioavailable 25(OH)D of young Asian Indian males working in outdoor and indoor environments”

Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies